tradingkey.logo
tradingkey.logo
検索

Biofrontera Inc

BFRI
ウォッチリストに追加
1.010USD
0.0000.00%
終値 07/02, 13:00ET15分遅れの株価
11.76M時価総額
損失額直近12ヶ月PER

詳細情報 Biofrontera Inc 企業名

Biofrontera Inc. is a biopharmaceutical company. The Company specializes in the development and commercialization of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT). The PDT treatment is used for the lesion-directed and field-directed treatment of actinic keratoses of mild-to-moderate severity on the face and scalp. The Company’s primary licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (the RhodoLED Lamps), are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions. The Company commercializes the drug-device combination Ameluz with the RhodoLED lamp series for PDT of AK, pre-cancerous skin lesions which may progress to invasive skin cancers. Its belixos ACTIVE CARE is a skin-soothing care foam for irritated and itchy skin, which can be used as basic care for atopic dermatitis and psoriasis as well as for soothing intensive care for everyday skin problems.

Biofrontera Incの企業情報

企業コードBFRI
会社名Biofrontera Inc
上場日Oct 14, 2021
最高経営責任者「CEO」Luebbert (Hermann)
従業員数92
証券種類Ordinary Share
決算期末Oct 14
本社所在地120 Presidential Way,
都市WOBURN
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号01801
電話番号17812451325
ウェブサイトhttps://www.biofrontera-us.com/
企業コードBFRI
上場日Oct 14, 2021
最高経営責任者「CEO」Luebbert (Hermann)

Biofrontera Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Prof. Dr. Hermann Luebbert, Ph.D.
Prof. Dr. Hermann Luebbert, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
290.21K
+47.38%
Mr. Eugene Frederick (Fred) Leffler, III
Mr. Eugene Frederick (Fred) Leffler, III
Chief Financial Officer
Chief Financial Officer
175.00K
+50.00%
Dr. John J. Borer, III
Dr. John J. Borer, III
Independent Director
Independent Director
--
--
Dr. Beth J. Hoffman, Ph.D.
Dr. Beth J. Hoffman, Ph.D.
Independent Director
Independent Director
--
--
Mr. Kevin D. Weber
Mr. Kevin D. Weber
Independent Director
Independent Director
--
--
Dr. Heikki Lanckriet, Ph.D.
Dr. Heikki Lanckriet, Ph.D.
Director
Director
--
--
Mr. George Jones
Mr. George Jones
Chief Commercial Officer
Chief Commercial Officer
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Prof. Dr. Hermann Luebbert, Ph.D.
Prof. Dr. Hermann Luebbert, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
290.21K
+47.38%
Mr. Eugene Frederick (Fred) Leffler, III
Mr. Eugene Frederick (Fred) Leffler, III
Chief Financial Officer
Chief Financial Officer
175.00K
+50.00%
Dr. John J. Borer, III
Dr. John J. Borer, III
Independent Director
Independent Director
--
--
Dr. Beth J. Hoffman, Ph.D.
Dr. Beth J. Hoffman, Ph.D.
Independent Director
Independent Director
--
--
Mr. Kevin D. Weber
Mr. Kevin D. Weber
Independent Director
Independent Director
--
--
Dr. Heikki Lanckriet, Ph.D.
Dr. Heikki Lanckriet, Ph.D.
Director
Director
--
--

よくある質問

Biofrontera Incの上位5名の株主は誰ですか?

Biofrontera Incの上位5名の株主は以下のとおりです。Prof. Dr. Hermann Luebbert, Ph.D.

Biofrontera Inc(BFRI)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Biofrontera Incの株式を保有している機関は37社あり、保有株式の総市場価値は約2.75Mで、全体の22.90%を占めています。2025Q4と比較して、機関の持ち株は-276665.00増加しています。